Search Results - "Gubonina, Irina V."

Bile acid dysmetabolism in inflammatory bowel diseases by Kuznetsova, Daria A., Lapin, Sergey V., Gubonina, Irina V.

“…Aim: To summarize the state-of-the-art data on the molecular mechanisms of bile acid (BA) synthesis and absorption, their impaired absorption and…”
Get full text

A clinical case of pyoderma gangrenosum as a severe extraintestinal manifestation of Crohn’s disease by Gubonina, Irina V., Grinevich, Vladimir B., Ramazanova, Silviya R., Petrachkov, Sergey A., Butrin, Yaroslav L.

“…Pyoderma gangrenosum is a rare neutrophilic dermatosis associated with a number of immune-mediated disorders, most frequently with inflammatory bowel disease…”
Get full text

Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study by Knyazev, O. V., Belousova, E. A., Abdulganieva, D. I., Gubonina, I. V., Kaibullayeva, J. A., Marakhouski, Yu. Kh, Chashkova, E. Yu, Shapina, M. V., Shchukina, O. B., Gegenava, B. B., Oliferuk, N. S.

“…Background: The analysis of data obtained from real world clinical practice of management of patients with inflammatory bowel diseases (IBD) is an effective…”
Get full text

Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians by Simanenkov, Vladimir I., Maev, Igor V., Tkacheva, Olga N., Alekseenko, Sergei A., Andreev, Dmitry, Bakulina, Natalia V., Bakulin, Igor G., Bordin, Dmitry S., Vlasov, Timur D., Vorobyeva, Natalya M., Grinevich, Vladimir B., Gubonina, Irina V., Drobizhev, Michail Y., Efremov, Nikolay S., Karateev, Andrey E., Kotovskaya, Yulia V., Kravchuk, Iurii, Krivoborodov, Grigory G., Kulchavenya, Ekaterina V., Lila, Aleksander M., Maevskaya, Marina V., Nekrasova, Anna S., Poluektova, Elena A., Popkova, Tatiana V., Sablin, Oleg A., Solovyeva, Olga I., Suvorov, Alexander N., Tarasova, Galina N., Trukhan, Dmity I., Fedotova, Anastasia V.

“…This document was produced with the support of the National Medical Association for the Study of Comorbidities (NASС). In 2021 the first multidisciplinary…”
Get full text